chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, hard knot, hurting with terrible pain down right arm. Swelling, redness, and fever, low grade.  Continued pain over next 3 days and nights. Swollen and hurting joints in fingers and leg pain. Dizzy and able to walk.
22 weeks pregnant, estimated delivery date 01/15/2022.  Around 26 hours post injection presented fatigue, pain in injection site, and left axillary pain. I have taken one dose of acetaminophen 500 mg.  At 48 hours post injection I still have pain in injection site and left axillary pain.
Nausea, dry heaving, vomiting, fatigue, fever, sweating - Started about 9pm and lasted for about 15 hours Headache - Started about 2pm the next day and lasted for about 17 hours Soreness at injection site - Started about 4pm and lasted for about 2 days
patient received different vaccine on first dose and 2nd dose. first dose was moderna, second dose is Pfizer
got sick as a dog, never got it sense, and never will; Initial information was received on 02-Jan-2022 regarding an unsolicited valid non-serious social media case received from a consumer/non-hcp.  This case involves an unknown demographics patient who got sick as a dog, never got it sense, and never will while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date in 1992 (reported as 30 years ago), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "got sick as a dog, never got it sense, and never will" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Got my flu shot 30 years ago, got sick as a dog, never got it sense, and never will It is unknown if the patient experienced any additional symptoms/events."  There were no lab data/results available.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got sick as a dog, never got it sense, and never will).  At time of reporting, the outcome was Unknown for the event got sick as a dog, never got it sense, and never will.
Kids arms are very sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Kids arms are very sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Kids arms are very sore). At the time of the report, VACCINATION SITE PAIN (Kids arms are very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8729), dose 2 via an unspecified route of administration on 14Apr2021 as single dose for COVID-19 immunization. The patient's medical history included ventricular extrasystoles. She has had PVCs in past but no other underlying conditions. The patient's concomitant medications were not reported. The patient experienced vertigo on 25Apr2021. Event took place after use of product. On an unspecified date, the patient experienced slight dizziness, slight headache, and increased number of PVC's, although she normally does get them. The outcome of the events was unknown.   No Follow-up attempts are needed. No further information is expected.
Patient had flu shot earlier in the day and had gone to ER later that night for headache, fevers, myalgias, and shortness of breath. His VS at the ER were temperature: 101.5 F, HR 103, RR: 14, BP: 147/84, SpO2: 98% on RA. CXR normal, WBC: 4.1, lactic acid 2.3, K: 3.2. Given 1 dose of azithromycin and ceftriaxone. The next day, had no further fevers, lactic acid returned to normal. Was felt to be reaction to recent vaccination or viral URI, and discharged home. No home antibiotics written.
Difficulty breathing, throat tightening. Started 15 minutes after co-adminitration of Tdap and attenuated influenza (preservative free). Pt 34 weeks pregnant at this time.
A report was received from a health care professional on 11/10/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
I had my vaccination on 04/25/2022. In 08/2022 I was having some pain but mild. I was diagnosed with Pericarditis. I was referred to a Cardiologist and a Rheumatologist. I was checked for Lupus which was negative. I was treated with medications and am still being followed up with specialty care. I am still having the same symptoms on 05/17/2023.
Initial report received on 25 July 2012 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a two-year-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 4 doses of PENTACEL; dose one received on 11 January 2010, dose two received on 15 March 2010, dose three received on 18 May 2010, and dose four received on 10 March 2011 (lot numbers, routes and sites of administration not reported). The subject developed cough and cold-like symptoms on 11 January 2012, approximately 10 months after the last dose. On 04 February 2012, the subject developed a paroxysmal cough with a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 07 February 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 07 February 2012 for five days. The subject was not hospitalized. At the time of final contact on 10 February 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 30 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Body weak; headache; Shivering; Fever; Vomiting; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of weakness generalized in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced weakness generalized (Verbatim: Body weak), headache (Verbatim: headache), shivering (Verbatim: Shivering), fever (Verbatim: Fever) and vomiting (Verbatim: Vomiting). The outcome of the weakness generalized, headache, shivering, fever and vomiting were resolved.   It was unknown if the reporter considered the weakness generalized, headache, shivering, fever and vomiting to be related to Shingles vaccine.     It was unknown if the company considered the weakness generalized, headache, shivering, fever and vomiting to be related to Shingles vaccine.   Additional Information: GSK receipt date: 10-JUL-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she did got vaccinated and also had a bad reaction to the second vaccine. The patient's body was weak, had a headache, shivering, fever and vomiting but the patient still think it was better to go through that, as it was just a few days, because shingles was much worse. The patient's sister in law had it, and it was really hard to see her suffering, and it happened a while ago and she was still in pain, so patient thought they say that the aches and pains never go away. The follow-up could not be possible as no contact details were available.
ATROPHY OF SHOULDER; BLOOD CLOT; FELT TWINGES IN THE RIGHT SHOULDER; SORENESS IN LEFT ARM; STRENGTH ISSUE WITH THE LEFT ARM AND CAN NOT MAKE A FIST /LOST STRENGTH IN ARM; LEFT SHOULDER STARTED BOTHERING HIM AND NOT HAVING A GOOD RANGE OF MOTION IN THE LEFT SHOULDER AND FEELING IT IN HIS PACK AND BICEPS; This spontaneous report received from a patient concerned a 61 year old male. The patient's height, and weight were not reported. The patient's past medical history included: bicycle accident, covid-19, lost weight, fever, and tooth absorption, and concurrent conditions included: non-alcohol, and other pre-existing medical conditions included: The patient had no known allergies. There was no drug abuse or illicit drug usage. He only smokes herbs like basil and coriander. He does not smoke cigarettes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, expiry: 23-AUG-2021) dose was not reported, 1 total, administered on 08-MAR-2021 for prophylactic vaccination. Concomitant medications included oxycodone/paracetamol.  On JAN-2020, Laboratory data included: COVID-19 virus test (NR: not provided) positive.  The patient felt fine and he had a good mobility with his shoulders but on On 15-MAR-2021, a week after vaccination the patient experienced left shoulder started bothering him and not having a good range of motion in the left shoulder and feeling it in his pack and biceps and soreness in left arm. The patient experienced strength issue with the left arm and can not make a fist /lost strength in arm. The patient mentioned that he felt the shot when the vaccine was injected and jumped and the injector asked him whether everything was okay.  The left shoulder issues was not getting better and was not getting worse either.  On 30-MAY-2021, the patient experienced felt twinges in the right shoulder.  On JUN-2021, treatment medications included: apixaban. On 26-JUN-2021, the patient experienced blood clot. On 02-AUG-2021, the patient experienced atrophy of shoulder. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100.7 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from felt twinges in the right shoulder, had not recovered from left shoulder started bothering him and not having a good range of motion in the left shoulder and feeling it in his pack and biceps, strength issue with the left arm and can not make a fist /lost strength in arm, atrophy of shoulder, and soreness in left arm, and the outcome of blood clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210832831 -covid-19 vaccine ad26.cov2.s- blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Received this clarification yesterday from the CDC/FDA. It goes against their recent push to simplify vaccination schedules by adding back in another product and having 2 different doses/ This is absolutely unsafe and continues to drive up stress and potential for unintentional errors due to multiple products and complicated dosing schedules. Please lobby for this to be changed. Moderna Bivalent DARK BLUE CAP is now used for ALL AGES (6 months+) to start a primary series - For patients 6 months - 5 years old: Dose 1 and Dose 2 should be administered from the Moderna Bivalent product with a dark blue cap (Previously the 6 year+ product with a gray label stating "booster doses only") 0.25mL per dose - For patients 6 months - 5 years old: Dose 3 (if needed) should be administered from the Moderna Bivalent product with a dark pink cap - 0.2mL per dose (2 doses per vial)
Vaccine given , but unsure of dose  exp date 10/13 or 10/30 (as in record).
There was an excursion from their freezer; There was an excursion from their freezer/they were administered to 118 patients.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from their freezer) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination. No Medical History information was reported.On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from their freezer) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.). On 01-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from their freezer) and EXPIRED PRODUCT ADMINISTERED (There was an excursion from their freezer/they were administered to 118 patients.) had resolved. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.There was an excursion from their freezer on 01-Oct-2021. They used the excursion tool but there was no option for the excursion they experienced. The tool only gives options for excursions above one hour and not less than, so she does not know how to do the analysis. She stated that her team already knows the recommended temperatures and wanted to know if the vials were still okay to be used because they were administered to 118 patients. Concomitant medications were not reported. Treatment information was not reported.
Patient reported itching in throat, on hands, neck, etc.  Hands were visibly reddened and neck as well.  Oral assessment not conducted.  Her vital signs were stable at 100/68, RR 20/min, HR 88, SPO2 98% Room air.  Patient immediately took her own Zyrtec orally and about 15 minutes later was still feeling same symptoms and due to severe reddened hands, and itching, and patient asked for oral Benadryl, which was give 25 mg po.  About 20 minutes later she reported that itching in throat was subsiding.  She said that this type of reaction is not at all unusual to some medications and substances.   Vitals at 1418 on 4/5/21: 104/69, RR 18/min, HR 77/hr, SPO2 98% Room air.  Patient left 5 minutes later and would notify her PCP.
Seizure occurred 48 hours after the TB test and Tetanus booster vaccine - after being seizure free for 2 years. She felt faint, weak and nauseous immediately following the TB test. She has had Tetanus shot before and no adverse reaction therefore seems related to TB as this was the first test she's ever received. The TB test was a PPD skin test- intradermal - Lot # C5039AA exp 11/16/2018, manufacturer Sanofi Pasteur.
Patient developed a local reaction at the site of where the vaccine was administered.  It is a raised are approximately 3cm x 7cm and patient decribes it as "itchy".
pATIENT PRESENTED WITH RED, PAPULAR LESIONS ON FACE,HEAD,TORSO,ARMS AND LEGS
chest congestion; throat hurts; arm hurt; body aches; Weakness; Headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI283, expiration date not reported), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. Medical history included 'Blood pressure'. Concomitant medication included doxorubicin hydrochloride (LIPISOL) for blood pressure. The patient reported that on 08Jan2021 (Friday), she had the COVID vaccine. On 09Jan2021 (Saturday), her arm hurt, she had body aches, and weakness. She also had a headache Saturday night. On 10Jan2021, she started getting chest congestion and her throat was hurting. When she was spitting out it felt like her throat was scratchy. Patient further reported that her arm does not hurt now. It still bothers her a little if she touches it, but doesn't if she doesn't touch it. Patient also reported that she does not have too much body aches now. She had a good dinner and took two of the 600mg Ibuprofen. It helped her. It still hurts a little. Patient reported that her weakness feels a little better. No fever and she has been checking her temperature. Patient clarified that her throat wasn't bothering her last night, but today it was bothering her. It was the bottom of her throat. She was supposed to go back on the 29th to get the other part. The patient was recovering from arm hurt, body aches, and weakness; has not recovered from chest congestion; and unknown outcome for the remaining events.
Resident appeared to be jaundice with yellow skin and eyes.  Resident also complained of not feeling well.  Urine was dark yellow.  Resident short of breath.  Resident was admitted to hospital and diagnosed with post-covid pneumonia.
Patient received vaccine and immediately felt dizzy and almost lost consciousness. He was brought in a wheelchair and vital signs taken. Patient refused transport to hospital. Advised to call 911 if any issues persist. Patient left to go home.
Swelling, skin is hot to touch, painful. Swelling is spreading as the day  progressed.
27 y/o female given VARIVAX on 7/18/17 developed maculo-papular/vesicular lesions to body-more concentrated on chest with associated severe itching/fatigue also with localized erythema (approx. 2 1/2" x 1 1/2") and dime size induration to injection site.
experienced covid like symptoms; This non-serious case was reported by a other health professional via call center representative and described the occurrence of suspected covid-19 in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced suspected covid-19 (Verbatim: experienced covid like symptoms). The outcome of the suspected covid-19 was not reported.   It was unknown if the reporter considered the suspected covid-19 to be related to Shingrix.     It was unknown if the company considered the suspected covid-19 to be related to Shingrix.   Additional Information: GSK receipt date: 25-JUL-2023 The reporter reported personal adverse reaction to Shingrix injection, experienced Covid like symptoms and declined 2nd dose. The reporter did not consent to follow up.
Pt has an area of redness and swelling the size of a 50 cent piece at injection site: c/o fever, chills and sweats onset 5/1/08. Also nose bleed. Fever on 5/1/08 102.9 now with intermittent fevers.
Patient's parent said patient had soreness, swelling, in Left arm. Said she took patient to the Urgent Care. Parent claims the physician said the client had a staph infection at the injection site.
Moderate to severe redness and swelling of approximately 8 inch diameter. Moderate pain. Fever spike 102. Fever reduced with acetaminophen, but all symptoms lasing 4 days.
pt recvd vax in july92;in jun 92 hep B surface antigen,surface antibody,core antibody all neg;in aug92 hep B surface antibody converted to pos;repeat hep B panel in aug93 showed conversion to pos of both the surface antibody & core antibody
I had extreme joint pain in my hips. I had nausea and diarrhea, which I still have. I had cough and congestion and extreme fatigue. My symptoms lasted for 12 days. I was prescribed Paxlovid, which tastes awful.
Patient c/o felling dizzy, extremely warm-sweaty after receiving FluMist. Patient stay in the office for half and hour. Vitals (WNL) taken when symptoms started and before leaving.
Patient reports he received his COVID booster on 11/13/21. States since Sunday he has been feeling poorly. Reports chills, sweats, weakness, and dizziness. Stated that on 11/18/21 he was sitting down eating an egg sandwich when he developed pressure in his midsternal chest. He does not believe it is associated with his food intake. He states it was localized to the mid chest. Reports it lasted for about an hour and the pain did not radiate. He rated it a 4 out of 10. Reports associated shortness of breath, diaphoresis, nausea, and lightheadedness. He denied any alleviating or worsening factors. States the patient spontaneously resolved after arriving to the ED, other symptoms persisted. Patient received DuoNebs, Solu-Medrol, aspirin, and nitropaste in the ER. Patient was admitted to the hospital for observation and management, cardiology was consulted. Patient was discharged on prednisone on 11/19/21
REALLY BAD LEG PAIN STABBING BURNING PAIN; This spontaneous report received from a consumer via a company representative (via social media) concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced really bad leg pain stabbing burning pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of really bad leg pain stabbing burning pain was not reported. This report was non-serious.
patient received the PNEUMOVAX 23 on 09/29/10 at the pharmacy. Patient informed staff that she had pneumonia last year and didn't want to get it again so she wanted the vaccine. The staff wasn't aware that she had had the vaccine the previous year. 4 hours after the 09/29/10 injection, the patient reported swelling, bruising -at injection site-, rash/hives -not at injection site-, and pain all the way up the arm.
Day 1: Swollen Left Arm, Enlarged Lymph nodes left armpit, shortness of breath, numbness and tingling in left hand, chest pain/pressure in chest. EMR/AMR called to r/o heart attack. Followed up with MD.  Day 2-3: swollen lymph nodes left arm, verbalized swelling in arm pit,  swelling in fingers, pain on left side of body from jaw to left hand.
Headache; Stomach discomfort; Diziness; This is a spontaneous report from a contactable consumer.  A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0164, Expiration date: unknown), via intramuscular, administered in left arm on 13apr2021 at 15.30 (at the age of 42-year-old) as 1st dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not undergo COVID-19 test prior to vaccination and Since the vaccination the patient has not been tested for COVID-19. On 13apr2021, 04:00, the patient experienced Headache, dizziness and a little stomach discomfort. The reporter assessed all events as non-serious. The outcome of the events Headache, dizziness and a little stomach discomfort was not recovered.  No follow-up attempts possible. No further information expected.
Swelling in upper left arm. Pain when using left arm to the side or behind the back. Pain while sleeping.